Cosibelimab
Cosibelimab (CK-301) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab exhibits antitumor efficacy[1].
Internal Reference:
antibody-sk14011
Size:
10mg